Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific…
Continue Reading
DevOps platform for digital health, blueBriX has introduced new micros frontends for its Patient Support Program and Remote Patient Monitoring modules, allowing easy integration into digital health applications and improving standards of care.The company…
Continue Reading
What You Should Know:
– Verix, a leader in AI-powered commercial operations solutions for the pharmaceutical industry, has announced the launch of its revolutionary GenAI Database Explorer.
– The GenAI-powered tool empowers sales reps with the…
Continue Reading
Series B Funding Round Led by Blue Heron Capital, with Participation from North Coast Ventures, Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25
Redi Health today announced that it has closed $14 million in Series B funding….
What You Should Know:
Today, Komodo Health unveiled a new self-service solution for rapid patient cohort analysis and insight generation.MapView is the industry’s first and most sophisticated analytics application that allows users without data science expertise to easily…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup company CombineAble.AI, which will speed up the development of therapeutics by addressing challenges…
Continue Reading
StuffThatWorks is a product developed by the same team that created Waze. It’s a global platform for real-world evidence on chronic conditions, powered by crowdsourcing and AI. In the near future, StuffThatWorks plans to…
Continue Reading
The health technology segment in India, which comprises about 10,000 startups, is projected to triple in value by 2028 as investors shift their focus towards businesses that can withstand economic disruptions.A new report by…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
Doron Aspitz, CEO, Verix
Next Best Action has been one of the most important approaches for sales in recent years, including for pharmaceuticals. But because selling pharma is significantly different than selling other products, pharma-oriented NBA approaches need to be significantly…
Continue Reading
